Patrick Frost, PhD

Patrick Frost, PhD

Jan 13, 2016

Group 6 Copy 46
-1
    Please wait...

    About This Project

    BBRI and Los Angeles VA Medical Center

    Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How do lichens withstand desiccation?

    Lichens, symbioses between fungi and algae, survive levels of desiccation lethal to most organisms. We recently...

    Probiotics for plants? Fighting insects by boosting corn immune systems

    Beneficial soil microorganisms can boost the plant immune system. We want to know if farming practices that...

    Can we increase human safety by understanding the language of bears?

    Fear of bears has gripped humans for centuries but no scientific effort has sought to understand how to...

    Backer Badge Funded